Cytarabine-impurities | Pharmaffiliates

cytarabine

Cytarabine is mainly used in the treatment of acute myeloid leukaemia, acute lymphocytic leukaemia and in lymphomas, where it is the backbone of induction chemotherapy.. Reference standards of Cytarabine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => cytarabine (383RB)
    [catalogue_number] => PA BP383RB
    [category_ids] => ,153,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => cytarabine-383rb-pabp383rb
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

cytarabine (383RB)


  • Catalogue No.:PA BP383RB

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA